Walgreens Boots Alliance reported its fiscal first quarter earnings, revealing stronger-than-expected revenue growth and adjusted earnings that surpassed estimates. Despite facing a significant net loss of $265 million, the drugstore chain demonstrated progress on its turnaround plan, leading to a more than 20% surge in its stock price. Analysts expressed cautious optimism as Walgreens continues to navigate strategic challenges, including store closures and rising costs. The company highlighted an uptick in sales at US pharmacies, which has bolstered confidence in its recovery efforts. As discussions about a potential sale to Sycamore Partners gain momentum, Walgreens remains in the spotlight following these promising financial results.